MedPath

AnaCardio AB

🇸🇪Sweden
Ownership
Holding
Employees
-
Market Cap
-
Website
http://anacardio.com

Clinical Trials

3

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
phase_1_2
1 (33.3%)

Phase Ib/IIa Trial With AC01 in Patients With HFrEF

Phase 1
Active, not recruiting
Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
First Posted Date
2022-12-08
Last Posted Date
2025-09-12
Lead Sponsor
AnaCardio AB
Target Recruit Count
62
Registration Number
NCT05642507
Locations
🇮🇹

Spedali Civilia di Brescia, Brescia, Italy

🇮🇹

Azienda Sanitaria Universitaria Integrata, Trieste, Italy

🇳🇱

Amsterdam University Medical Centre, Amsterdam, Netherlands

and more 10 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.